伏立康唑治疗期间出现的幻觉。
Hallucinations during voriconazole therapy.
作者信息
Zonios Dimitrios I, Gea-Banacloche Juan, Childs Richard, Bennett John E
机构信息
Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
出版信息
Clin Infect Dis. 2008 Jul 1;47(1):e7-e10. doi: 10.1086/588844.
Abstract
As part of a prospective natural history cohort study of voriconazole toxicity, we describe the characteristics of 12 of 72 voriconazole-treated patients who experienced hallucinations from March 2006 through November 2007. Hallucinations associated with voriconazole use are not uncommon. Doctors should be aware of this complication, and the recipients of the drug should be reassured that the hallucinations are an effect of the drug.
摘要
作为一项关于伏立康唑毒性的前瞻性自然史队列研究的一部分，我们描述了2006年3月至2007年11月期间72例接受伏立康唑治疗的患者中出现幻觉的12例患者的特征。与使用伏立康唑相关的幻觉并不罕见。医生应意识到这一并发症，并且应向药物接受者保证幻觉是药物的一种作用。
相似文献
1
Hallucinations during voriconazole therapy.伏立康唑治疗期间出现的幻觉。
Clin Infect Dis. 2008 Jul 1;47(1):e7-e10. doi: 10.1086/588844.
2
Voriconazole-induced musical hallucinations.伏立康唑引起的音乐幻觉。
Infection. 2004 Oct;32(5):293-5. doi: 10.1007/s15010-004-3121-1.
3
[Complex visual hallucinations induced by voriconazole].[伏立康唑诱发的复杂视幻觉]
Med Clin (Barc). 2009 Jun 27;133(4):156-7. doi: 10.1016/j.medcli.2008.09.022.
4
[Hallucinosis as side effect of voriconazole].[幻觉症作为伏立康唑的副作用]
Rev Clin Esp. 2005 Dec;205(12):632-3. doi: 10.1016/s0014-2565(05)72663-1.
5
Voriconazole toxicity related to polymorphisms in CYP2C19.与CYP2C19基因多态性相关的伏立康唑毒性
Intern Med J. 2011 Apr;41(4):364-5. doi: 10.1111/j.1445-5994.2011.02454.x.
6
Adverse reactions to voriconazole.伏立康唑的不良反应。
Clin Infect Dis. 2004 Oct 15;39(8):1241-4. doi: 10.1086/424662. Epub 2004 Sep 23.
7
Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.肺移植受者侵袭性肺曲霉病采用伏立康唑和卡泊芬净联合治疗的临床转归。
J Clin Pharm Ther. 2010 Feb;35(1):49-53. doi: 10.1111/j.1365-2710.2009.01061.x.
8
Visual disturbance comorbid with hallucination caused by voriconazole in the Japanese population.在日本人群中，伏立康唑引起的视力障碍与幻觉并存。
Int J Hematol. 2008 Jul;88(1):3-6. doi: 10.1007/s12185-008-0114-3. Epub 2008 Jun 24.
9
Hallucinations during voriconazole therapy: who is at higher risk and could benefit from therapeutic drug monitoring?伏立康唑治疗期间的幻觉：谁的风险更高以及谁能从治疗药物监测中获益？
Ther Drug Monit. 2009 Feb;31(1):135-6. doi: 10.1097/FTD.0b013e3181947901.
10
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.伏立康唑与两性霉素B脂质体用于中性粒细胞减少症伴持续发热患者的经验性抗真菌治疗比较。
N Engl J Med. 2002 Jan 24;346(4):225-34. doi: 10.1056/NEJM200201243460403.
引用本文的文献
1
"Crocus Flower": Voriconazole-Induced Hallucinations and Visual Disturbances in a Patient with Recurrent Severe Vulvovaginitis-A Case Report on Irrational Drug Use.“番红花花”：伏立康唑致复发性严重外阴阴道炎患者幻觉及视觉障碍——不合理用药病例报告
Reports (MDPI). 2024 Nov 22;7(4):105. doi: 10.3390/reports7040105.
2
Data mining and safety analysis of voriconazole in patients with a hematological malignant tumor based on the FAERS database: differences between children and adults.基于FAERS数据库的血液系统恶性肿瘤患者伏立康唑的数据挖掘与安全性分析：儿童与成人的差异
Front Pharmacol. 2025 Jan 24;16:1524702. doi: 10.3389/fphar.2025.1524702. eCollection 2025.
3
Characteristics of voriconazole-induced visual disturbances and hallucinations: case reports and literature review.伏立康唑引起的视觉障碍和幻觉的特征：病例报告及文献综述
Front Pharmacol. 2024 Nov 7;15:1420046. doi: 10.3389/fphar.2024.1420046. eCollection 2024.
4
Drug-induced musical hallucination.药物性音乐幻觉
Front Pharmacol. 2024 May 22;15:1401237. doi: 10.3389/fphar.2024.1401237. eCollection 2024.
5
Diagnosis and management of cryptococcal meningitis in HIV-infected adults.HIV 感染者隐球菌性脑膜炎的诊断与治疗。
Clin Microbiol Rev. 2023 Dec 20;36(4):e0015622. doi: 10.1128/cmr.00156-22. Epub 2023 Nov 28.
6
Voriconazole-induced psychosis in rhino-orbital invasive aspergillosis.伏立康唑致侵袭性鼻窦眶曲霉病致精神障碍。
BMJ Case Rep. 2023 Oct 11;16(10):e254790. doi: 10.1136/bcr-2023-254790.
7
The impact of gene polymorphism and hepatic insufficiency on voriconazole dose adjustment in invasive fungal infection individuals.基因多态性和肝功能不全对侵袭性真菌感染患者伏立康唑剂量调整的影响。
Front Genet. 2023 Aug 24;14:1242711. doi: 10.3389/fgene.2023.1242711. eCollection 2023.
8
Pharmacokinetic interaction of voriconazole and clarithromycin in Pakistani healthy male volunteers: a single dose, randomized, crossover, open-label study.伏立康唑与克拉霉素在巴基斯坦健康男性志愿者中的药代动力学相互作用：一项单剂量、随机、交叉、开放标签研究。
Front Pharmacol. 2023 Jun 9;14:1134803. doi: 10.3389/fphar.2023.1134803. eCollection 2023.
9
Oral voriconazole monotherapy for fungal keratitis: efficacy, safety, and factors associated with outcomes.口服伏立康唑单药治疗真菌性角膜炎：疗效、安全性及与预后相关的因素。
Front Med (Lausanne). 2023 May 11;10:1174264. doi: 10.3389/fmed.2023.1174264. eCollection 2023.
10
Treatment of Invasive Aspergillosis: How It's Going, Where It's Heading.侵袭性曲霉病的治疗：现状与展望。
Mycopathologia. 2023 Oct;188(5):667-681. doi: 10.1007/s11046-023-00727-z. Epub 2023 Apr 26.
本文引用的文献
1
Adverse effects of voriconazole: analysis of the French Pharmacovigilance Database.伏立康唑的不良反应：法国药物警戒数据库分析
Ann Pharmacother. 2007 May;41(5):755-63. doi: 10.1345/aph.1H671. Epub 2007 Apr 24.
2
Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring.伏立康唑的神经系统不良事件：治疗药物监测的证据
Swiss Med Wkly. 2006 Nov 11;136(45-46):739-42. doi: 10.4414/smw.2006.11547.
3
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.伏立康唑与卡泊芬净联合作为实体器官移植受者侵袭性曲霉病的初始治疗：一项前瞻性、多中心、观察性研究。
Transplantation. 2006 Feb 15;81(3):320-6. doi: 10.1097/01.tp.0000202421.94822.f7.
4
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial.伏立康唑与两性霉素B序贯氟康唑治疗非中性粒细胞减少患者念珠菌血症的随机非劣效性试验
Lancet. 2005;366(9495):1435-42. doi: 10.1016/S0140-6736(05)67490-9.
5
Voriconazole-induced musical hallucinations.伏立康唑引起的音乐幻觉。
Infection. 2004 Oct;32(5):293-5. doi: 10.1007/s15010-004-3121-1.
6
Adverse reactions to voriconazole.伏立康唑的不良反应。
Clin Infect Dis. 2004 Oct 15;39(8):1241-4. doi: 10.1086/424662. Epub 2004 Sep 23.
7
Development and validation of a high-performance liquid chromatography assay for voriconazole.伏立康唑高效液相色谱测定法的建立与验证
Antimicrob Agents Chemother. 2003 Jul;47(7):2348-50. doi: 10.1128/AAC.47.7.2348-2350.2003.
8
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.伏立康唑与两性霉素B用于侵袭性曲霉病的初始治疗比较
N Engl J Med. 2002 Aug 8;347(6):408-15. doi: 10.1056/NEJMoa020191.
9
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis.伏立康唑治疗急性侵袭性曲霉病的疗效与安全性。
Clin Infect Dis. 2002 Mar 1;34(5):563-71. doi: 10.1086/324620. Epub 2002 Jan 22.
10
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.伏立康唑与两性霉素B脂质体用于中性粒细胞减少症伴持续发热患者的经验性抗真菌治疗比较。
N Engl J Med. 2002 Jan 24;346(4):225-34. doi: 10.1056/NEJM200201243460403.
Zotero 插件